<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>BACKGROUND: <z:chebi fb="0" ids="35664">Statins</z:chebi>, <z:chebi fb="0" ids="35664">HMG-CoA reductase inhibitors</z:chebi>, are widely prescribed drugs for <z:e sem="disease" ids="C0242339" disease_type="Disease or Syndrome" abbrv="">dyslipidemias</z:e> </plain></SENT>
<SENT sid="1" pm="."><plain>Recent studies have indicated number of cholesterol independent actions of <z:chebi fb="0" ids="35664">statins</z:chebi> including their beneficial effects on vascular <z:e sem="disease" ids="C0856169" disease_type="Disease or Syndrome" abbrv="">endothelial dysfunction</z:e> and <z:e sem="disease" ids="C0233794" disease_type="Mental or Behavioral Dysfunction" abbrv="">memory deficits</z:e> associated with <z:hpo ids='HP_0000726'>dementia</z:hpo> of Alzheimer's type </plain></SENT>
<SENT sid="2" pm="."><plain>However the potential of <z:chebi fb="0" ids="35664">statins</z:chebi> in <z:hpo ids='HP_0000726'>dementia</z:hpo> of vascular origin still remains to be explored </plain></SENT>
<SENT sid="3" pm="."><plain>Therefore, the present study has been designed to investigate the effect of <z:chebi fb="0" ids="39548">Atorvastatin</z:chebi> &amp; Pitavastatin on vascular <z:e sem="disease" ids="C0856169" disease_type="Disease or Syndrome" abbrv="">endothelial dysfunction</z:e> associated <z:e sem="disease" ids="C0233794" disease_type="Mental or Behavioral Dysfunction" abbrv="">memory deficits</z:e> in rats </plain></SENT>
<SENT sid="4" pm="."><plain>In this study <z:chebi fb="0" ids="16643">L-Methionine</z:chebi> induced vascular <z:hpo ids='HP_0000726'>dementia</z:hpo> was assessed by <z:mp ids='MP_0001465'>Morris water-maze</z:mp> (MWM) test </plain></SENT>
<SENT sid="5" pm="."><plain>Biochemical analysis was also performed to unfold possible mechanism of <z:chebi fb="0" ids="35664">statins</z:chebi> mediated modulation of vascular <z:hpo ids='HP_0000726'>dementia</z:hpo> </plain></SENT>
<SENT sid="6" pm="."><plain>RESULTS: <z:chebi fb="0" ids="16643">L-Methionine</z:chebi> produced <z:e sem="disease" ids="C0856169" disease_type="Disease or Syndrome" abbrv="">endothelial dysfunction</z:e> as reflected by significant decrease in serum <z:chebi fb="95" ids="16301">nitrite</z:chebi> concentration </plain></SENT>
<SENT sid="7" pm="."><plain><z:chebi fb="0" ids="16643">L-Methionine</z:chebi> treated rats performed poorly on MWM indicating impairment of memory as well </plain></SENT>
<SENT sid="8" pm="."><plain>These rats also showed a significant rise in brain <z:mp ids='MP_0003674'>oxidative stress</z:mp>, acetylcholinesterase (AChE) activity and serum total cholesterol levels </plain></SENT>
<SENT sid="9" pm="."><plain>Both <z:chebi fb="0" ids="39548">Atorvastatin</z:chebi> as well as Pitavastatin attenuated <z:chebi fb="0" ids="16643">L-Methionine</z:chebi> induced <z:e sem="disease" ids="C0856169" disease_type="Disease or Syndrome" abbrv="">endothelial dysfunction</z:e> associated <z:e sem="disease" ids="C0233794" disease_type="Mental or Behavioral Dysfunction" abbrv="">memory deficits</z:e> </plain></SENT>
<SENT sid="10" pm="."><plain><z:chebi fb="0" ids="35664">Statins</z:chebi> also reversed <z:chebi fb="0" ids="16643">L-Methionine</z:chebi> induced rise in brain <z:mp ids='MP_0003674'>oxidative stress</z:mp>, AChE activity and serum cholesterol </plain></SENT>
<SENT sid="11" pm="."><plain>CONCLUSION: The beneficial effects of <z:chebi fb="0" ids="35664">statins</z:chebi> may be attributed to their multiple effects and the study highlights the potential of these drugs in vascular <z:hpo ids='HP_0000726'>dementia</z:hpo> </plain></SENT>
</text></document>